These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7537216)

  • 1. Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.
    Mhashilkar AM; Bagley J; Chen SY; Szilvay AM; Helland DG; Marasco WA
    EMBO J; 1995 Apr; 14(7):1542-51. PubMed ID: 7537216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
    J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
    Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
    Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.
    Wu Y; Duan L; Zhu M; Hu B; Kubota S; Bagasra O; Pomerantz RJ
    J Virol; 1996 May; 70(5):3290-7. PubMed ID: 8627813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies.
    Bai J; Sui J; Zhu RY; Tallarico AS; Gennari F; Zhang D; Marasco WA
    J Biol Chem; 2003 Jan; 278(3):1433-42. PubMed ID: 12401780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new intrabody directed against the N-terminal region of human p53.
    Cohen PA; Mani JC; Lane DP
    Oncogene; 1998 Nov; 17(19):2445-56. PubMed ID: 9824155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.
    Scala G; Ruocco MR; Ambrosino C; Mallardo M; Giordano V; Baldassarre F; Dragonetti E; Quinto I; Venuta S
    J Exp Med; 1994 Mar; 179(3):961-71. PubMed ID: 8113688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies.
    Strube RW; Chen SY
    J Immunol Methods; 2002 May; 263(1-2):149-67. PubMed ID: 12009211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR.
    Tosi G; Meazza R; De Lerma Barbaro A; D'Agostino A; Mazza S; Corradin G; Albini A; Noonan DM; Ferrini S; Accolla RS
    Eur J Immunol; 2000 Apr; 30(4):1120-6. PubMed ID: 10760801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Rhim H; Rice AP
    Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
    Su Y; Popik W; Pitha PM
    J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps.
    Jeang KT; Berkhout B
    J Biol Chem; 1992 Sep; 267(25):17891-9. PubMed ID: 1517225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
    Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
    Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct interaction of the human I-mfa domain-containing protein, HIC, with HIV-1 Tat results in cytoplasmic sequestration and control of Tat activity.
    Gautier VW; Sheehy N; Duffy M; Hashimoto K; Hall WW
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16362-7. PubMed ID: 16260749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
    J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.